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Canonical epidermal growth factor receptor (EGFR) interaction with cognate ligands 
such as EGF triggers receptor dimerization, activation and a well-characterised 
endocytic trafficking pathway that leads to termination of signalling via lysosomal 
degradation of the receptor. We
1
, and others
2,3
, have investigated the existence of an 
alternative route of EGFR trafficking, that occurs as a cellular response to stress and 
in the absence of ligand. Following exposure to oxidative stress, triggered by a range 
of insults such as ultraviolet light C (UVC) or the chemotherapeutic agent cisplatin, 
EGFR is internalised in a p38 MAP kinase-dependent manner
2,3
, but, contrary to 
ligand-stimulated EGFR internalisation, this occurs in the absence of receptor 
activation or ubiquitination
1
. Post-internalisation, ligand-stimulated EGFR undergo 
ubiquitin-dependent interaction with the Endosomal Sorting Complex Required for 
Transport (ESCRT machinery) that sorts them onto intraluminal vesicles (ILVs) of 
multivesicular bodies (MVBs). This spatially segregates them from non-ubiquitinated 
receptors that remain on the MVB limiting membrane and undergo Rab11-dependent 
recycling to the plasma membrane. When all the recycling receptors have been 
removed, these MVBs fuse with lysosomes and the ILVs containing ligand-stimulated 
EGFR are degraded. In early endosomes, stress-exposed EGFR is sorted away from 
its ligand-stimulated counterpart into a distinct population of relatively stable MVBs 
where they accumulate on both the ILVs and the MVB limiting membrane. 
Segregation of ligand-stimulated and stress-induced EGFR in early endosomes is 
orchestrated by the WASH complex
1
, presumably involving its actin polymerisation-
driven endosomal subdomain specification properties
4
. Analysis of exogenously-
expressed potential cargoes that might accompany stress-exposed EGFR into this 
particular subtype of MVB lead us to conclude that these MVBs represent endosomal 
precursors to lysosome-related organelles, such as melanosomes. Their presence not 
only in specialised cell types such as melanocytes
5
, but, also, as shown in our study
1
, 
in non-specialised cells such as HeLa, suggests that they have additional functions. 
 
Establishing the functional significance of the perinuclear MVBs in which stress-
induced EGFR accumulates has been facilitated by our identification of molecular 
requirements regulating EGFR retention in these MVBs. Inhibition of p38 after 
accumulation of stress-induced EGFR in perinuclear MVBs caused the EGFR to 
reappear on the plasma membrane, demonstrating a second role for p38 in regulating 
stress-induced EGFR trafficking, distinct from its previously identified role in EGFR 
internalisation. Plasma membrane reappearance of EGFR that was previously 
sequestered within MVBs also indicates that EGFR-containing ILVs can back-fuse 
with the MVB limiting membrane to allow recycling. Retention of stress-induced 
EGFR in MVBs also involves the ESCRT machinery and the ESCRT-accessory 
protein, ALIX, which is necessary for the sorting of non-ubiquitinated EGFR onto 
ILVs
1
. P38/ESCRT/ALIX-dependent accumulation of EGFR in perinuclear MVBs is 
accompanied by slow, but sustained, EGFR activation and downstream signalling. 
Surprisingly, and contrary to receptor activity following ligand binding, EGFR 
activation does not occur if internalisation from the plasma membrane is abrogated
1
. 
As maintenance of signalling is enabled by the ALIX-driven sequestration of stress-
exposed EGFR in MVBs
1
, we hypothesise that repeated rounds of ESCRT and ALIX-
dependent internalisation and back-fusion of EGFR to and from ILVs ensures 
continued accessibility of the receptor to downstream signalling molecules. This 
hypothesis is reinforced by the previously suggested role of ALIX in ILV back-fusion 
events during nucleocapsid release to the cytosol from endosomes in the process of 
viral infection
6
.  
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Signalling from EGFR in perinuclear MVBs delayed apoptosis induced by UVC and 
cisplatin, suggesting that sequestration of EGFR in this subtype of MVB could 
contribute to the acquisition of resistance to chemotherapy. This highlights the 
importance of determining the trafficking response of EGFR in tumours in response 
to therapy. This is of particular relevance to the design of combination therapies that 
utilise chemotherapeutic agents in combination with anti-EGFR therapies.  
 
The study of the atypical pathway of stress-triggered EGFR trafficking and its 
comparison with the better-characterised ligand-stimulated one has extended our 
knowledge of the variety of mechanisms regulating EGFR trafficking along the 
endocytic pathway. It has also highlighted the multiplicity of destinations for this, and 
presumably other signalling receptors and the pivotal effects of the different 
trafficking outcomes on signalling. Moreover, our study reveals the existence of at 
least two coexisting subpopulations of MVBs, which, in parallel to the previously 
identified different subpopulations of ILVs within the same MVB
7
, highlights the 
complexity associated with this trafficking organelle and its key role in regulating 
receptor signalling in mammalian cells. 
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Figure 1 
Ligand-bound, ubiquitinated EGFR are activated and signal at the plasma membrane. 
Post internalisation they undergo ESCRT-mediated sorting to ILVs of MVBs that 
separates them from non-ubiquitinated recycling receptors and promotes their 
lysosomal degradation. Stress-induced non-ubiquitinated EGFR are activated post 
internalisation and sequestered on ILVs of a separate subtype of signalling MVBs by 
the action of p38, WASH complex and ESCRT/ALIX.  
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